Myeloid Leukemias Completed Phase 1 / 2 Trials for Daunorubicin (DB00694)

Also known as: Leukemia, Myeloid / Myeloid leukaemia / Myeloid Leukemia / Leukemia myeloid / Non-lymphoblastic leukaemia NOS / Leukemic granulocytic / Non-lymphoblastic leukemia NOS / Unspecified myeloid leukaemia / Unspecified myeloid leukemia / Leukaemia myelogenous / Leukemia myelogenous / Myelocytic leukaemia / Myelocytic leukemia / Leukemia granulocytic NOS / Leukaemia granulocytic NOS / Leukaemia granulocytic / Leukemia granulocytic / Leukaemia myeloid / Myeloid leukemia NOS / Myeloid leukaemia NOS

IndicationStatusPhase
DBCOND0042450 (Myeloid Leukemias)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00129168Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)Treatment